Pluviaendo Pharmaceuticals

Vonage Pharma, formerly known as PluviaEndo Pharmaceuticals, is a multinational pharmaceutical company headquartered in Istanbul, Turkey. The company specializes in the development, manufacturing, and global supply of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) across various therapeutic areas, including addiction treatment, analgesics, cardiovascular health, and metabolic disorders. Vonage Pharma is particularly recognized for its expertise in opioid medications and alkaloid extraction, offering products such as methadone, naltrexone, and oxycodone. The company operates under Good Manufacturing Practice (GMP) standards and provides services such as out-licensing, private label manufacturing, and technical support for dossier development. With a focus on expanding its international footprint, Vonage Pharma targets markets in the ASEAN region, Europe, and the Middle East.